HM Payson & Co’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.5K Buy
1,072
+1
+0.1% +$12 ﹤0.01% 890
2026
Q1
$6.42K Buy
1,071
+34
+3% +$256 ﹤0.01% 954
2025
Q4
$7.44K Sell
1,037
-54
-5% -$427 ﹤0.01% 943
2025
Q3
$11.7K Buy
1,091
+4
+0.4% +$39 ﹤0.01% 891
2025
Q2
$10.5K Sell
1,087
-188
-15% -$1.94K ﹤0.01% 850
2025
Q1
$19K Sell
1,275
-205
-14% -$3.15K ﹤0.01% 799
2024
Q4
$22.1K Sell
1,480
-234
-14% -$3.81K ﹤0.01% 761
2024
Q3
$32.8K Buy
1,714
+371
+28% +$7.69K ﹤0.01% 698
2024
Q2
$27.8K Buy
1,343
+70
+5% +$1.39K ﹤0.01% 702
2024
Q1
$23.9K Sell
1,273
-11
-0.9% -$189 ﹤0.01% 720
2023
Q4
$18.5K Sell
1,284
-1,840
-59% -$25K ﹤0.01% 752
2023
Q3
$54.2K Sell
3,124
-461
-13% -$9.61K ﹤0.01% 562
2023
Q2
$74.6K Sell
3,585
-333
-8% -$7.24K ﹤0.01% 523
2023
Q1
$92.1K Sell
3,918
-158
-4% -$4.24K ﹤0.01% 484
2022
Q4
$114K Sell
4,076
-1,905
-32% -$48.7K ﹤0.01% 444
2022
Q3
$140K Sell
5,981
-1,064
-15% -$32.1K ﹤0.01% 424
2022
Q2
$238K Sell
7,045
-3,441
-33% -$121K 0.01% 343
2022
Q1
$367K Sell
10,486
-3,074
-23% -$105K 0.01% 312
2021
Q4
$413K Sell
13,560
-5,663
-29% -$184K 0.01% 306
2021
Q3
$630K Sell
19,223
-3,518
-15% -$113K 0.02% 252
2021
Q2
$688K Buy
+22,741
New +$749K 0.02% 236

Other funds holding OGN

HM Payson & Co's OGN Position: Q2 2026 in Review

HM Payson & Co increased its Organon & Co (OGN) stake by 0.09% in Q2 2026, buying an estimated $12 and bringing the position to 1,072 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

HM Payson & Co first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $688K in Q2 2021. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • HM Payson & Co held 1,072 shares of Organon & Co worth $14.5K as of Q2 2026.
  • HM Payson & Co bought 1 Organon & Co share in Q2 2026, an estimated $12.
  • Organon & Co made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #890 holding.
  • HM Payson & Co first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • HM Payson & Co's Organon & Co position peaked at $688K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.